Jefferson Hills, PANCT06449638Now EnrollingIRB Ready

Diabetic Foot Ulcer (DFU) Clinical Trial in Jefferson Hills, PA

Access cutting-edge diabetic foot ulcer (dfu) treatment through this clinical trial at a research site in Jefferson Hills. Study-provided care at no cost to qualified participants.

Sponsored by StimLabs

Quick Self-Assessment

See if you qualify for this Jefferson Hills location

Preparing your pre-screening questions…

Expert Care in Jefferson Hills

Access diabetic foot ulcer (dfu) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic foot ulcer (dfu) treatment provided free

Apply for This Jefferson Hills Location

Check if you qualify for this diabetic foot ulcer (dfu) clinical trial in Jefferson Hills, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Jefferson Hills

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Jefferson Hills site if eligible
  4. 4Begin participation

About This Diabetic Foot Ulcer (DFU) Study in Jefferson Hills

The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.

Sponsor: StimLabs

Who Can Participate

Inclusion Criteria

At least 18 years of age or older.
Diagnosis of type 1 or 2 Diabetes mellitus.
At enrollment, target ulcer with a minimum surface area of 1.0 cm2 and a maximum surface area of 25.0 cm2 measured post debridement with the MolecuLight® Imaging Device.
The target ulcer must have been present for a minimum of 4 weeks and a maximum of 52 weeks of standard of care, prior to the initial screening visit.
The target ulcer must be located on the foot with at least 50% of the ulcer below the malleolus.
The target ulcer must be full thickness without exposed bone.
The affected limb must have adequate perfusion confirmed by vascular assessment. Any of the following methods performed within 3 months of the first screening visit are acceptable:
Ankle-Brachial Index (ABI) between 0.7 and ≤ 1.3;
Toe-Brachial Index (TBI) ≥ 0.6;
Transcutaneous Oxygen Measurement (TCOM) ≥ 40 mmHg;
Pulse Volume Resistance (PVR): biphasic.
If the potential subject has two or more ulcers, they must be separated by at least 2 cm. The largest ulcer satisfying the inclusion and

Exclusion Criteria

will be designated as the target ulcer.
Target ulcers located on the plantar aspect of the foot must be offloaded for at least 14 days prior to enrollment.
The potential subject must consent to using the prescribed offloading method for the duration of the study.
The potential subject must agree to attend the weekly study visits required by the protocol.
The potential subject must be willing and able to participate in the informed consent process. Exclusion Criteria:
The potential subject is known to have a life expectancy of \< 6 months.
The potential subject's target ulcer is not secondary to diabetes.
The target ulcer is infected or there is cellulitis in the surrounding skin.
The target ulcer exposes tendon or bone.
There is evidence of osteomyelitis complicating the target ulcer.
There is an infection in the target ulcer or in a remote location that requires systemic antibiotic therapy.
The potential subject is receiving immunosuppressants (including systemic corticosteroids at doses greater than 10 mg of prednisone per day or equivalent) or cytotoxic chemotherapy or is taking medications that the PI believes will interfere with wound healing (e.g., biologics).
The potential subject is taking hydroxyurea.
The potential subject has applied topical steroids to the ulcer surface within one month of initial screening.
The potential subject with a previous partial amputation on the affected foot that results in a deformity that impedes proper offloading of the target ulcer.
The potential subject has glycated hemoglobin (HbA1c) greater than or equal to 12% within 3 months of the initial screening visit.
The surface area of the target ulcer has reduced in size by more than 20% in the 2 weeks prior to the initial screening visit ("historical" run-in period). MolecuLight Imaging Device is not required for measurements taken during the historical run-in period (e.g., calculating surface area using length X width is acceptable).
The surface area measurement of the Target ulcer decreases by 20% or more during the 2-week screening phase: the 2 weeks from the initial screening visit (S1) to the TV-1 visit during which time the potential subject received SOC.
The potential subject has an acute Charcot foot, or an inactive Charcot foot, which impedes proper offloading of the target ulcer.
Women who are pregnant or considering becoming pregnant within the next 6 months are excluded.
The potential subject has end stage renal disease requiring dialysis.
Participation in a clinical trial involving treatment with an investigational product within the previous 30 days.
A potential subject who, in the opinion of the investigator, has a medical or psychological condition that may interfere with study assessments.
The target ulcer was treated with hyperbaric oxygen therapy (HBOT) or a Cellular, Acellular, Matrix-like Product (CAMP) in the 30 days prior to the initial screening visit.
The potential subject has a malnutrition indicator score \<17 as measured on the Mini Nutrition Assessment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Jefferson Hills?

Yes, this clinical trial (NCT06449638) has an active research site in Jefferson Hills, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Foot Ulcer (DFU) Treatment Options in Jefferson Hills, PA

If you're searching for diabetic foot ulcer (dfu) treatment options in Jefferson Hills, PA, this clinical trial (NCT06449638) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Jefferson Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic foot ulcer (dfu) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic foot ulcer (dfu) clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Jefferson Hills, PA

See all essential tremor clinical trials recruiting in Jefferson Hills — not just this study.

Browse Essential Tremor Trials in Jefferson Hills →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Jefferson Hills?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Jefferson Hills, PA